References
- Quinn TC, Zacarias FR, St John RK. HIV and HTLV-I infections in the Americas: a regional perspective. Medicine (Baltimore) 1989: 68(4): 189–209
- Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990: 322(14): 941–9
- Sandler SG, Dodd RY, Fang CT. Diagnostic tests for HIV infection: serology. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. AIDS: etiology, diagnosis, treatment, and prevention. Philadelphia: JB Lippincott, 1988: 121–6
- Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. JAMA 1989: 262(24): 3395–7
- Fang C, Le P, Mallory D, et al. Western blot patterns of antibodies to human immunodeficiency virus (HIV). Transfusion 1987: 27(6): 539
- Biberfeld G, Bredberg-Raden U, Bottiger B, et al. Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. (Letter) Lancet 1986: 2(8501): 289–90
- Dock NL, Lamberson HV Jr, O'Brien TA, et al. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 1988: 28(5): 412–8
- Lange JM, Coutinho RA, Krone WJ, et al. Distinct IgG recognition patterns during progression of subclinicafand clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. BMJ (Clin Res) 1986: 292(6515): 228–30
- Schochetman G, Ou CY, Jones WK. Polymerase chain reaction. J Infect Dis 1988: 158(6): 1154–7